21188 S. Chen-Kiang: Biology of plasma cells.
Best Practice & Res. Clin. Haem. 18/4 (2005), 493-507.

21166 David Dingli/.../Jorge Pacheco: Cancer phenotype as the outcome
of an evolutionary game between normal and malignant cells.
Brit. J. Cancer ... (2009), 17p.

21204 Hartmut Goldschmidt: Grundbegriffe des multiplen Myeloms.
Internet 2008, 38p.

21228 Hartmut Goldschmidt/Annemarie Angerer/Orhan Sezer: Info-Rubrik
Plasmozytom/Multiples Myelom. DLH-INFO 1. September 2009, 12-15.

21241 Jonathan Keats/.../P. Leif Bergsagel: Promiscuous mutations activate
the noncanonical NF-kB pathway in multiple myeloma.
Cancer Cell 12 (2007), 131-144.

21187 G. Morgan/F. Davies/M. Linet: Myeloma aetiology and epidemiology.
Biomed. Pharmacother. 56 (2002), 223-234.

21248 S. Rajkumar/Francis Buadi: Multiple myeloma - new staging systems
for diagnosis, prognosis and response evaluation.
Best Practice Res. Clin. Haem. 20/4 (2007), 665-680.

21232 Jerome Tanner: Myeloma. Chelsea House 2008, 120p. Eur 28.
Very elementary. (wg)

21423 Christian Taverna: Multiples Myelom - erkennen und behandeln.
UNI-MED 2009, 80p. Eur 39.

21390 Fenghuang Zhan/.../John Shaughnessy: The molecular classification
of multiple myeloma. Blood 108 (2006), 2020-2028.

21152 ZZ: Mieloma multiplo. AIL Ferrara ca. 2003, 2p.

21214 ZZ: What you need to know about multiple myeloma. NCI 2008, 43p.

21179 ZZ: Berichte über den 12. Intl. Myeloma Workshop
(26.2. - 1.3. 2009 in Washington, DC). Internet 2009, 10p.

21178 ZZ: Berichte über den 2nd Heidelberg Myeloma Workshop
(15. - 16. Mai 2009). Internet 2009, 18p.

21206 ZZ: Ankündigung zum 2. Heidelberger Myeloma-Workshop.
Internet 2009, 2p.

21207 ZZ: Myelompatienten profitieren von verbesserter Diagnostik
und Therapie. Internet 2009, 6p. Zum 2. Heidelberger Myeloma-Workshop.